Rayamajhi A, Acharya B, Khanal B. TP53 Mutation as Molecular Marker in the Assessment of Surgical Margin Status in Head and Neck Squamous Cell Carcinoma. Nep. J. Cancer. 2021;5(1):27-32. doi:10.3126/njc.v5i1.41317